Label Changes for:
Arimidex (anastrozole) Tablets, 1 mg
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
6.0 ADVERSE REACTIONS
6.2 Post-Marketing Experience
- hypercalcemia (with or without an increase in parathyroid hormone) added to trigger finger
NOTE: revised the text throughout the entire patient package insert
6 ADVERSE REACTIONS
6.1 Clinical Trials Experience
Other Adverse Reactions
- ...safety results from ATAC trial...